Inhibition of the Epstein–Barr virus lytic cycle by protoapigenone
Open Access
- 1 August 2011
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 92 (8) , 1760-1768
Abstract
Epstein–Barr virus (EBV) expresses two transcription factors, Rta and Zta, during the immediate–early stage of the lytic cycle to activate the transcription of early and late genes. This study finds that 0.31 mM protoapigenone fromThelypteris torresiana(Gaud.) inhibits the expression of EBV lytic proteins, including Rta, Zta, EA-D and VCA, in P3HR1 cells after lytic induction with 12-O-tetradecanoylphorbol-13-acetate and sodium butyrate. The lack of expression of EBV lytic proteins after protoapigenone treatment is attributed to the inhibition of the transactivation function of Zta because protoapigenone reduces the transactivation activity of Zta and Gal4–Zta, which contains the transactivation domain of Zta fused with Gal4. In contrast, protoapigenone does not affect the ability of Rta to activate a promoter that contains an Rta-response element, showing that the inhibition is unrelated to Rta. Furthermore, in a lactate dehydrogenase assay, protoapigenone is not toxic to P3HR1 cells at the concentrations that inhibit the function of Zta, showing that protoapigenone is valuable for studying the function of Zta and preventing EBV lytic proliferation.Keywords
This publication has 41 references indexed in Scilit:
- MCAF1 and synergistic activation of the transcription of Epstein–Barr virus lytic genes by Rta and ZtaNucleic Acids Research, 2010
- Inhibition of the Epstein–Barr virus lytic cycle by moronic acidAntiviral Research, 2010
- Protoapigenone, a Novel Flavonoid, Induces Apoptosis in Human Prostate Cancer Cells through Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase 1/2The Journal of Pharmacology and Experimental Therapeutics, 2008
- Enhancement of Transactivation Activity of Rta of Epstein-Barr Virus by RanBPMJournal of Molecular Biology, 2008
- Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1Nucleic Acids Research, 2005
- Marked Variation in Response of Consensus Binding Elements for the Rta Protein of Epstein-Barr VirusJournal of Virology, 2005
- Inhibition of the Epstein–Barr virus lytic cycle by Zta-targeted RNA interferenceJournal of General Virology, 2004
- Inhibition of Epstein–Barr virus lytic cycle by (−)-epigallocatechin gallateBiochemical and Biophysical Research Communications, 2003
- Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal KinasesJournal of Virology, 2000
- Antiplatelet Aggregation Constituents from Annona purpureaJournal of Natural Products, 1998